{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:15:52Z","timestamp":1788002152393,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Vice-Chancellery of Research and Technology of Isfahan University of Medical Sciences","award":["199657"],"award-info":[{"award-number":["199657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10529-026-03755-z","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T23:47:59Z","timestamp":1784504879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Production of mannosylated hrsACE2 by baculovirus expression system; the way to remove and redirect SARS-CoV-2 viral particles to macrophages"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-5672","authenticated-orcid":false,"given":"Hanie-Sadat","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-1984","authenticated-orcid":false,"given":"Nafiseh","family":"Esmaeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-5558","authenticated-orcid":false,"given":"Marc G.","family":"Aucoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-8260","authenticated-orcid":false,"given":"Ali","family":"Jahanian-Najafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"3755_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046959","volume":"7","author":"G Ahl\u00e9n","year":"2012","unstructured":"Ahl\u00e9n G, Strindelius L, Johansson T et al (2012) Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses. PLoS One 7:e46959. https:\/\/doi.org\/10.1371\/journal.pone.0046959","journal-title":"PLoS One"},{"key":"3755_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2485840","volume":"21","author":"A Akingbola","year":"2025","unstructured":"Akingbola A, Adewole O, Adegbesan A et al (2025) From Wuhan to Omicron K.P2 strain: a comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine. Hum Vaccin Immunother 21:2485840. https:\/\/doi.org\/10.1080\/21645515.2025.2485840","journal-title":"Hum Vaccin Immunother"},{"key":"3755_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.tips.2022.06.011","volume":"43","author":"T Arimori","year":"2022","unstructured":"Arimori T, Ikemura N, Okamoto T et al (2022) Engineering ACE2 decoy receptors to combat viral escapability. Trends Pharmacol Sci 43:838\u2013851. https:\/\/doi.org\/10.1016\/j.tips.2022.06.011","journal-title":"Trends Pharmacol Sci"},{"key":"3755_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s43141-022-00368-7","volume":"20","author":"MA Azali","year":"2022","unstructured":"Azali MA, Mohamed S, Harun A et al (2022) Application of baculovirus expression vector system (BEV) for COVID-19 diagnostics and therapeutics: a review. J Genet Eng Biotechnol 20:98. https:\/\/doi.org\/10.1186\/s43141-022-00368-7","journal-title":"J Genet Eng Biotechnol"},{"key":"3755_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","volume":"23","author":"DR Burton","year":"2023","unstructured":"Burton DR (2023) Antiviral neutralizing antibodies: from in vitro to in vivo activity. Nat Rev Immunol 23:720\u2013734. https:\/\/doi.org\/10.1038\/s41577-023-00858-w","journal-title":"Nat Rev Immunol"},{"key":"3755_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.18.344622","author":"KK Chan","year":"2020","unstructured":"Chan KK, Tan TJC, Narayanan KK, Procko E (2020) An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. bioRxiv. https:\/\/doi.org\/10.1101\/2020.10.18.344622","journal-title":"bioRxiv"},{"key":"3755_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158155","volume":"25","author":"Y-S Chung","year":"2024","unstructured":"Chung Y-S, Lam C-Y, Tan P-H et al (2024) Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies. Int J Mol Sci 25:8155. https:\/\/doi.org\/10.3390\/ijms25158155","journal-title":"Int J Mol Sci"},{"key":"3755_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/btpr.1842","volume":"30","author":"A Contreras-G\u00f3mez","year":"2014","unstructured":"Contreras-G\u00f3mez A, S\u00e1nchez-Mir\u00f3n A, Garc\u00eda-Camacho F et al (2014) Protein production using the baculovirus-insect cell expression system. Biotechnol Prog 30:1\u201318. https:\/\/doi.org\/10.1002\/btpr.1842","journal-title":"Biotechnol Prog"},{"key":"3755_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116178","volume":"25","author":"A Gambadauro","year":"2024","unstructured":"Gambadauro A, Galletta F, Li Pomi A et al (2024) Immune response to respiratory viral infections. Int J Mol Sci 25:6178. https:\/\/doi.org\/10.3390\/ijms25116178","journal-title":"Int J Mol Sci"},{"key":"3755_CR10","doi-asserted-by":"publisher","first-page":"28046","DOI":"10.1073\/pnas.2016093117","volume":"117","author":"A Glasgow","year":"2020","unstructured":"Glasgow A, Glasgow J, Limonta D et al (2020) Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proc Natl Acad Sci USA 117:28046\u201328055. https:\/\/doi.org\/10.1073\/pnas.2016093117","journal-title":"Proc Natl Acad Sci USA"},{"key":"3755_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.immuni.2022.05.005","volume":"55","author":"H Gruell","year":"2022","unstructured":"Gruell H, Vanshylla K, Weber T et al (2022) Antibody-mediated neutralization of SARS-CoV-2. Immunity 55:925\u2013944. https:\/\/doi.org\/10.1016\/j.immuni.2022.05.005","journal-title":"Immunity"},{"key":"3755_CR12","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1007\/s11033-022-07132-7","volume":"49","author":"A Jafari","year":"2022","unstructured":"Jafari A, Danesh Pouya F, Niknam Z et al (2022) Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Mol Biol Rep 49:4943\u20134957. https:\/\/doi.org\/10.1007\/s11033-022-07132-7","journal-title":"Mol Biol Rep"},{"key":"3755_CR13","first-page":"133","volume":"7","author":"A Jahanian-Najafabadi","year":"2012","unstructured":"Jahanian-Najafabadi A, Bouzari S, Oloomi M et al (2012) Assessment of selective toxicity of insect cell expressed recombinant A1-GMCSF protein toward GMCSF receptor bearing tumor cells. Res Pharm Sci 7:133\u2013140","journal-title":"Res Pharm Sci"},{"key":"3755_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/prot.26140","volume":"89","author":"W Jing","year":"2021","unstructured":"Jing W, Procko E (2021) ACE2-based decoy receptors for SARS coronavirus 2. Proteins 89:1065\u20131078. https:\/\/doi.org\/10.1002\/prot.26140","journal-title":"Proteins"},{"key":"3755_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01181","author":"RB Kennedy","year":"2020","unstructured":"Kennedy RB, Ovsyannikova IG, Palese P, Poland GA (2020) Current challenges in vaccinology. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01181","journal-title":"Front Immunol"},{"key":"3755_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00768-24","volume":"15","author":"DL Kober","year":"2024","unstructured":"Kober DL, Caballero Van Dyke MC, Eitson JL et al (2024) Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo. Mbio 15:e00768-24. https:\/\/doi.org\/10.1128\/mbio.00768-24","journal-title":"Mbio"},{"key":"3755_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752227","volume":"12","author":"S Kumar","year":"2021","unstructured":"Kumar S, \u00c7al\u0131\u015fkan DM, Janowski J et al (2021) Beyond vaccines: clinical status of prospective COVID-19 therapeutics. Front Immunol 12:752227. https:\/\/doi.org\/10.3389\/fimmu.2021.752227","journal-title":"Front Immunol"},{"key":"3755_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","volume":"36","author":"C Lei","year":"2020","unstructured":"Lei C, Yang J, Hu J, Sun X (2020) On the calculation of TCID50 for quantitation of virus infectivity. Virol Sin 36:141\u2013144. https:\/\/doi.org\/10.1007\/s12250-020-00230-5","journal-title":"Virol Sin"},{"key":"3755_CR19","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1039\/D5MA00115C","volume":"6","author":"J-W Lim","year":"2025","unstructured":"Lim J-W, Lee S-E, Park H et al (2025) Mannose-decorated polymersomes loaded with antigens and TLR7\/8 agonists targeting antigen-presenting cells for enhancing vaccine efficacy. Mater Adv 6:5948\u20135958. https:\/\/doi.org\/10.1039\/D5MA00115C","journal-title":"Mater Adv"},{"key":"3755_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pep.2013.05.009","volume":"90","author":"F Liu","year":"2013","unstructured":"Liu F, Wu X, Li L et al (2013) Use of baculovirus expression system for generation of virus-like particles: successes and challenges. Protein Expr Purif 90:104\u2013116. https:\/\/doi.org\/10.1016\/j.pep.2013.05.009","journal-title":"Protein Expr Purif"},{"key":"3755_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41371-021-00636-y","volume":"36","author":"BK Maiti","year":"2022","unstructured":"Maiti BK (2022) Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection. J Hum Hypertens 36:488\u2013492. https:\/\/doi.org\/10.1038\/s41371-021-00636-y","journal-title":"J Hum Hypertens"},{"key":"3755_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202115230","volume":"14","author":"V Monteil","year":"2022","unstructured":"Monteil V, Eaton B, Postnikova E et al (2022) Clinical grade ACE2 as a universal agent to block SARS\u2010CoV\u20102 variants. EMBO Mol Med 14:EMMM202115230. https:\/\/doi.org\/10.15252\/emmm.202115230","journal-title":"EMBO Mol Med"},{"key":"3755_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/glycob\/cwm008","volume":"17","author":"SM Van Patten","year":"2007","unstructured":"Van Patten SM, Hughes H, Huff MR et al (2007) Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. Glycobiology 17:467\u2013478. https:\/\/doi.org\/10.1093\/glycob\/cwm008","journal-title":"Glycobiology"},{"key":"3755_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031370","volume":"25","author":"M Paurevi\u0107","year":"2024","unstructured":"Paurevi\u0107 M, \u0160rajer Gajdo\u0161ik M, Ribi\u0107 R (2024) Mannose ligands for mannose receptor targeting. Int J Mol Sci 25:1370. https:\/\/doi.org\/10.3390\/ijms25031370","journal-title":"Int J Mol Sci"},{"key":"3755_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5562\/cca1827","volume":"84","author":"R Ribi\u0107","year":"2011","unstructured":"Ribi\u0107 R, Habjanec L, Vrane\u0161i\u0107 B et al (2011) Synthesis and biological evaluation of new mannose derived immunomodulating adamantyltripeptides. Croat Chem Acta 84:233\u2013244. https:\/\/doi.org\/10.5562\/cca1827","journal-title":"Croat Chem Acta"},{"key":"3755_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/138945007782151360","volume":"8","author":"X Shi","year":"2007","unstructured":"Shi X, Jarvis DL (2007) Protein N-glycosylation in the baculovirus-insect cell system. Curr Drug Targets 8:1116\u20131125. https:\/\/doi.org\/10.2174\/138945007782151360","journal-title":"Curr Drug Targets"},{"key":"3755_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20653-8","volume":"12","author":"J-H Tian","year":"2021","unstructured":"Tian J-H, Patel N, Haupt R et al (2021) SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun 12:372. https:\/\/doi.org\/10.1038\/s41467-020-20653-8","journal-title":"Nat Commun"},{"key":"3755_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02130","volume":"11","author":"M Trovato","year":"2020","unstructured":"Trovato M, Sartorius R, D\u2019Apice L et al (2020) Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol 11:2130. https:\/\/doi.org\/10.3389\/fimmu.2020.02130","journal-title":"Front Immunol"},{"key":"3755_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.53854\/liim-3204-5","volume":"32","author":"BM Ukoaka","year":"2024","unstructured":"Ukoaka BM, Okesanya OJ, Daniel FM et al (2024) Updated WHO list of emerging pathogens for a potential future pandemic: implications for public health and global preparedness. Infez Med 32:463\u2013477. https:\/\/doi.org\/10.53854\/liim-3204-5","journal-title":"Infez Med"},{"key":"3755_CR30","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers C, Hales P, Kaushik V et al (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838\u201314843. https:\/\/doi.org\/10.1074\/jbc.M200581200","journal-title":"J Biol Chem"},{"key":"3755_CR31","doi-asserted-by":"publisher","first-page":"E1214","DOI":"10.1503\/cmaj.220688","volume":"194","author":"S Vohra-Miller","year":"2022","unstructured":"Vohra-Miller S, Schwartz IS (2022) NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ 194:E1214. https:\/\/doi.org\/10.1503\/cmaj.220688","journal-title":"CMAJ"},{"key":"3755_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.714","volume":"5","author":"R Wang","year":"2024","unstructured":"Wang R, Lan C, Benlagha K et al (2024) The interaction of innate immune and adaptive immune system. MedComm 5:e714. https:\/\/doi.org\/10.1002\/mco2.714","journal-title":"MedComm"},{"key":"3755_CR33","doi-asserted-by":"publisher","first-page":"17341","DOI":"10.1021\/acsomega.8b02264","volume":"3","author":"Y Wu","year":"2018","unstructured":"Wu Y, Yan C, He J et al (2018) Reversible mannosylation as a covalent binding adjuvant enhances immune responses for porcine circovirus type 2 vaccine. ACS Omega 3:17341\u201317347. https:\/\/doi.org\/10.1021\/acsomega.8b02264","journal-title":"ACS Omega"},{"key":"3755_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","volume":"55","author":"J Wysocki","year":"2010","unstructured":"Wysocki J, Ye M, Rodriguez E et al (2010) Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension 55:90\u201398. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.138420","journal-title":"Hypertension"},{"key":"3755_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125246","volume":"14","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jiao B, Qu L et al (2023) The development of COVID-19 treatment. Front Immunol 14:1125246. https:\/\/doi.org\/10.3389\/fimmu.2023.1125246","journal-title":"Front Immunol"},{"key":"3755_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765034","volume":"12","author":"HJP van der Zande","year":"2021","unstructured":"van der Zande HJP, Nitsche D, Schlautmann L et al (2021) The mannose receptor: from endocytic receptor and biomarker to regulator of (meta)inflammation. Front Immunol 12:765034. https:\/\/doi.org\/10.3389\/fimmu.2021.765034","journal-title":"Front Immunol"},{"key":"3755_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41421-021-00302-0","volume":"7","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zeng E, Zhang L et al (2021) Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo. Cell Discov 7:65. https:\/\/doi.org\/10.1038\/s41421-021-00302-0","journal-title":"Cell Discov"},{"key":"3755_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41541-022-00597-4","volume":"7","author":"F Zhao","year":"2022","unstructured":"Zhao F, Zai X, Zhang Z et al (2022) Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ Vaccines 7:167. https:\/\/doi.org\/10.1038\/s41541-022-00597-4","journal-title":"NPJ Vaccines"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-026-03755-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-026-03755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:18:36Z","timestamp":1787998716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-026-03755-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3755"],"URL":"https:\/\/doi.org\/10.1007\/s10529-026-03755-z","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}